Tolerance to oral anticancer agent treatment in older adults with cancer: a secondary analysis of data from electronic health records and a pilot study of patient-reported outcomes

BACKGROUND: More than 60% of cancer cases occur in older adults, and many are treated with oral anticancer agents. Yet, the treatment tolerability in older adults has not been fully understood due to their underrepresentation in oncology clinical trials, creating challenges for treatment decision-ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yun, Mason, Madilyn, Cho, Youmin, Chittiprolu, Ankita, Zhang, Xingyu, Harden, Karen, Gong, Yang, Harris, Marcelline R., Barton, Debra L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440580/
https://www.ncbi.nlm.nih.gov/pubmed/36057578
http://dx.doi.org/10.1186/s12885-022-10026-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440580/
https://www.ncbi.nlm.nih.gov/pubmed/36057578
http://dx.doi.org/10.1186/s12885-022-10026-3

Ejemplares similares